The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. * Valeant Pharmaceuticals International Inc and Pershing Square Capital Management are planning to raise their offer to acquire the Botox maker Allergan Inc by $15 a share, according to a person with knowledge of the matter. (nyti.ms/10Nmby5)* A judge in London's High Court ordered Goldman Sachs Group Inc on Tuesday to pay some of the Libyan Investment Authority's costs for fighting the bank's efforts to dismiss a lawsuit that the authority filed against Goldman in January. (nyti.ms/1ncqH33)
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN traded higher by 1.68% or $3.08/share to $186.20. In the past year, the shares have traded as low as $88.34 and as high as $189.41. On average, 2065290 shares of AGN exchange hands on a given day and today's volume is recorded at 6312307.
The Goldman Sachs Group, Inc. (Goldman Sachs), is a global investment banking, securities and investment management firm that provides a range of financial services to a substantial and diversified client base that includes corporations, financial institutions, governments and high-net-worth individuals. Shares of GS fell by 1.96% or $-3.68/share to $183.80. In the past year, the shares have traded as low as $151.65 and as high as $189.50. On average, 2538300 shares of GS exchange hands on a given day and today's volume is recorded at 2927062.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 2.48% or $-3.18/share to $125.23. In the past year, the shares have traded as low as $102.60 and as high as $153.10. On average, 2675780 shares of VRX exchange hands on a given day and today's volume is recorded at 4235317.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 2.19% or $-3.13/share to $139.84. In the past year, the shares have traded as low as $107.30 and as high as $170.45. On average, 450594 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 336678.
Source
